666 related articles for article (PubMed ID: 14999485)
1. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
3. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
4. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
5. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
6. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features of patients associated with anti-GM1b antibody].
Tatsumoto M; Yuki N; Odaka M; Hirata K
Rinsho Shinkeigaku; 2003 Apr; 43(4):149-53. PubMed ID: 12884824
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features of neuropathies in a group of patients associated with anti-GalNAc-GD1a antibody].
Tatsumoto M; Odaka M; Koga M; Hirata K; Yuki N
Rinsho Shinkeigaku; 2004 Aug; 44(8):508-12. PubMed ID: 15471085
[TBL] [Abstract][Full Text] [Related]
9. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside.
Yuki N; Ang CW; Koga M; Jacobs BC; van Doorn PA; Hirata K; van der Meché FG
Ann Neurol; 2000 Mar; 47(3):314-21. PubMed ID: 10716250
[TBL] [Abstract][Full Text] [Related]
11. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
[TBL] [Abstract][Full Text] [Related]
12. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
[TBL] [Abstract][Full Text] [Related]
13. Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom.
Koga M; Yuki N; Hirata K
J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):513-6. PubMed ID: 10201426
[TBL] [Abstract][Full Text] [Related]
14. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.
Taguchi K; Ren J; Utsunomiya I; Aoyagi H; Fujita N; Ariga T; Miyatake T; Yoshino H
J Neurol Sci; 2004 Oct; 225(1-2):91-8. PubMed ID: 15465091
[TBL] [Abstract][Full Text] [Related]
15. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
[TBL] [Abstract][Full Text] [Related]
16. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.
Nagashima T; Koga M; Odaka M; Hirata K; Yuki N
Arch Neurol; 2007 Oct; 64(10):1519-23. PubMed ID: 17923636
[TBL] [Abstract][Full Text] [Related]
17. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
[TBL] [Abstract][Full Text] [Related]
18. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
[TBL] [Abstract][Full Text] [Related]
19. Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia.
Kamakura K; Kaida K; Kusunoki S; Miyamoto N; Masaki T; Nakamura R; Motoyoshi K; Fukuda J
J Peripher Nerv Syst; 2005 Jun; 10(2):190-201. PubMed ID: 15958130
[TBL] [Abstract][Full Text] [Related]
20. Anti-ganglioside complex antibodies associated with severe disability in GBS.
Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
